From bench to bedside: discovery of ovarian cancer biomarkers using high-throughput technologies in the past decade
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
From bench to bedside: discovery of ovarian cancer biomarkers using high-throughput technologies in the past decade
Authors
Keywords
-
Journal
Biomarkers in Medicine
Volume 6, Issue 5, Pages 613-625
Publisher
Future Medicine Ltd
Online
2012-10-17
DOI
10.2217/bmm.12.70
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Systems Approach to the Proteomic Identification of Novel Cancer Biomarkers
- (2013) Sharon Pitteri et al. DISEASE MARKERS
- Risk of Malignancy in Sonographically Confirmed Ovarian Tumors
- (2012) RACHEL WARE MILLER et al. CLINICAL OBSTETRICS AND GYNECOLOGY
- Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses
- (2012) Toon Van Gorp et al. EUROPEAN JOURNAL OF CANCER
- Differential Diagnosis of a Pelvic Mass
- (2012) Robert C. Bast et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass
- (2012) Karolina Partheen et al. Journal of Gynecologic Oncology
- Epitope presentation is an important determinant of the utility of antigens identified from protein arrays in the development of autoantibody diagnostic assays
- (2012) Mairead A. Murphy et al. Journal of Proteomics
- Separation of kallikrein 6 glycoprotein subpopulations in biological fluids by anion-exchange chromatography coupled to ELISA and identification by mass spectrometry
- (2012) Uros Kuzmanov et al. PROTEOMICS
- A review of current proteomics technologies with a survey on their widespread use in reproductive biology investigations
- (2012) P.C. Wright et al. THERIOGENOLOGY
- Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
- (2011) Lee E. Moore et al. CANCER
- Serum Human Epididymis Protein 4 and Risk for Ovarian Malignancy Algorithm as New Diagnostic and Prognostic Tools for Epithelial Ovarian Cancer Management
- (2011) E. Bandiera et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens
- (2011) D. W. Cramer et al. Cancer Prevention Research
- A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer
- (2011) Claus Høgdall et al. GYNECOLOGIC ONCOLOGY
- Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer
- (2011) Charlotte H. Clarke et al. GYNECOLOGIC ONCOLOGY
- No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting
- (2011) Francis Jacob et al. GYNECOLOGIC ONCOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Proteomic analysis of formalin-fixed paraffin-embedded tissue by MALDI imaging mass spectrometry
- (2011) Rita Casadonte et al. Nature Protocols
- Performance of the American College of Obstetricians and Gynecologistsʼ Ovarian Tumor Referral Guidelines With a Multivariate Index Assay
- (2011) Rachel Ware Miller et al. OBSTETRICS AND GYNECOLOGY
- Effectiveness of a Multivariate Index Assay in the Preoperative Assessment of Ovarian Tumors
- (2011) Frederick R. Ueland et al. OBSTETRICS AND GYNECOLOGY
- A New Method for Isolation of Interstitial Fluid from Human Solid Tumors Applied to Proteomic Analysis of Ovarian Carcinoma Tissue
- (2011) Hanne Haslene-Hox et al. PLoS One
- Comprehensive Serum Profiling for the Discovery of Epithelial Ovarian Cancer Biomarkers
- (2011) Ping Yip et al. PLoS One
- Proteomic analysis of human epithelial ovarian cancer xenografts in immunodeficient mice exposed to chronic psychological stress
- (2011) Jun Gao et al. Science China-Life Sciences
- HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases
- (2011) Rafael Molina et al. TUMOR BIOLOGY
- Investigation of the Ovarian and Prostate Cancer Peptidome for Candidate Early Detection Markers Using a Novel Nanoparticle Biomarker Capture Technology
- (2010) Claudia Fredolini et al. AAPS Journal
- Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass
- (2010) Richard G. Moore et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Measuring the intra-individual variability of the plasma proteome in the chicken model of spontaneous ovarian adenocarcinoma
- (2010) Adam M. Hawkridge et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Road from Discovery to Clinical Diagnostics: Lessons Learned from the First FDA-Cleared In Vitro Diagnostic Multivariate Index Assay of Proteomic Biomarkers
- (2010) Z. Zhang et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- A Recipe for Proteomics Diagnostic Test Development: The OVA1 Test, from Biomarker Discovery to FDA Clearance
- (2010) E. T. Fung CLINICAL CHEMISTRY
- Quality of care in advanced ovarian cancer: The importance of provider specialty
- (2010) Cheryl Mercado et al. GYNECOLOGIC ONCOLOGY
- Increasing the Effectiveness of Referral of Ovarian Masses From Cancer Unit to Cancer Center by Using a Higher Referral Value of the Risk of Malignancy Index
- (2010) Amer Raza et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Cancer Biomarkers: Can We Turn Recent Failures into Success?
- (2010) E. P. Diamandis JNCI-Journal of the National Cancer Institute
- Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data
- (2010) MP Coleman et al. LANCET
- Evaluation of the risk of malignancy index in daily clinical management of adnexal masses
- (2009) Petronella A.J. van den Akker et al. GYNECOLOGIC ONCOLOGY
- Maintenance Therapy for Ovarian Cancer: Of Helsinki and Hippocrates
- (2009) William Patrick McGuire JOURNAL OF CLINICAL ONCOLOGY
- Comparative Proteomic Analysis of Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line and Its Resistant Counterpart A2780TC1 by 2D-DIGE: The Role of ERp57
- (2009) Lucia Cicchillitti et al. JOURNAL OF PROTEOME RESEARCH
- Glycoproteomics of paclitaxel resistance in human epithelial ovarian cancer cell lines: Towards the identification of putative biomarkers
- (2009) Michela Di Michele et al. Journal of Proteomics
- Integrated Proteomic Analysis of Human Cancer Cells and Plasma from Tumor Bearing Mice for Ovarian Cancer Biomarker Discovery
- (2009) Sharon J. Pitteri et al. PLoS One
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
- (2008) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
- Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: A systematic review
- (2008) Andreas du Bois et al. GYNECOLOGIC ONCOLOGY
- The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
- (2007) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now